home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Oral and Inhalatory Drug Delivery Systems

 
  April 16, 2015  
     
 
CfPA-The Center for Professional Advancement, 90 Minute Accredited Online Training
June 9, 2015 at 10:00 a.m.–11:30 a.m. (ET)


Who Should Attend?
The online course will be of value to professionals working in research and product development in pharmaceutical, biotech and related sectors, who want to learn how to characterize and understand complex dosage forms performance, and to identify and address key factors affecting such performance. The course is addressed to:

  • Pharmaceutical R&D Scientists and Managers
  • Business Development and Intellectual Property Managers
  • Biotechnologists
  • Regulatory Affairs Personnel
  • Technology Transfer Managers
  • Investors in Biomedical, Pharma and New Technologies
Scientists and Managers from academia, start-ups, drug discovery and early drug development companies will benefit from the course. Technical and business staffs who serve in CROs and CMOs environment using a broad spectrum of delivery technologies will also derive significant benefit.

 

Course Description
This course will be available On Demand: June 10, 2015

This 90- minute accredited online training will provide an understanding of how to address and solve the critical aspects affecting complex drug product performance. Emphasis will be put on characterization of in vitro and in vivo behavior of delivery systems, based on the use of state-of-the-art-technologies. Case examples, specifically taken from industrial experience, will be briefly described to emphasize the practical advantages of early characterization of dosage form performance.
 
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
Dr. Pierandrea Esposito; Cofounder and Associate Director, SiTec PharmaBio

Dr. Pierandrea Esposito is Cofounder and Associate Director at SiTec PharmaBio, a company focused on the development of innovative technologies for drug delivery, based on dense-CO2 processing. He has 25 years experience in pharmaceutical and biotech industry, and held several director or management positions at Esteve, SiTec Consulting, Critical Pharmaceuticals Ltd, Serono, and Vectopharma. Dr. Esposito has experience in pharmaceutical development, from late discovery-feasibility stages to clinical phases and preregistration activities, developing drug products based on delivery systems, advanced formulations, and conjugation technologies. His scientific interests focus in micro and nanoparticulate systems, biomolecules delivery, in drug solubilization/absorption of small molecules for oral and transmucosal routes, in physical pharmacy. He is also interested in the application of imaging techniques to drug delivery.

Dr. Esposito graduated in Pharmaceutical Chemistry and Technology, University of Trieste, (Italy). He has been visiting scientist at College of Pharmacy, University of Kentucky (USA), attached professor at University of Sao Paulo (Brasil), and at University Piemonte Orientale “A.Avogadro”, Novara (Italy). He coauthored 22 publications (research articles, reviews, book chapters), and 45 abstracts; he is a coinventor in 16 patents, and a member of Scientific Editorial Boards of several international journals.
 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: sberg@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.